Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) FCF Margin (2021 - 2025)

Historic FCF Margin for Biofrontera (BFRIW) over the last 5 years, with Q3 2025 value amounting to 54.36%.

  • Biofrontera's FCF Margin fell 404400.0% to 54.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 32.19%, marking a year-over-year increase of 193200.0%. This contributed to the annual value of 27.63% for FY2024, which is 454700.0% up from last year.
  • Latest data reveals that Biofrontera reported FCF Margin of 54.36% as of Q3 2025, which was down 404400.0% from 34.15% recorded in Q2 2025.
  • In the past 5 years, Biofrontera's FCF Margin ranged from a high of 1.82% in Q2 2022 and a low of 229.05% during Q4 2021
  • Moreover, its 5-year median value for FCF Margin was 42.75% (2024), whereas its average is 61.72%.
  • As far as peak fluctuations go, Biofrontera's FCF Margin soared by 1474900bps in 2022, and later crashed by -1783700bps in 2023.
  • Biofrontera's FCF Margin (Quarter) stood at 229.05% in 2021, then skyrocketed by 64bps to 81.56% in 2022, then decreased by -3bps to 83.64% in 2023, then surged by 91bps to 7.64% in 2024, then tumbled by -611bps to 54.36% in 2025.
  • Its last three reported values are 54.36% in Q3 2025, 34.15% for Q2 2025, and 47.97% during Q1 2025.